Biologics are often particularly prone to particle formation. Particle analysis becomes more important.
Why you should consider defining your secondary packaging strategy as early as possible.
In the production of high-quality pharmaceuticals, aiming for excellence in all production areas is the overarching goal of process optimization.
When launching parenteral lyophilized products, it is fundamental to make decisions about the diluent.
The demand for stability studies is consistently increasing due to rising complexity and regulatory requirements.
V-CRT® achieves quality standards that come close to the performance of isolators while still offering the flexibility advantages of RABS.
From drug development to commercial filling and beyond, the a CDMO partner offers everything at a single source.
cGMP regulations are a key component of the pharmaceutical industry to ensure the quality of drugs.
Future oriented pharmaceutical processes – a key to success